Warning: Undefined variable $page_cluster_id in /home3/thegood9/public_html/website_70aad9ea/header.php on line 29



Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Tag Directory / RESEARCHFUNDING     showing 1–5 of 5   RSS


for: Saturday, April 18, 2026



Three gene therapy pioneers just won the Breakthrough Prize. This is their story

Ryan Cross / endpoints - A trio of scientists behind the first gene therapy approved in the United States have been awarded a Breakthrough Prize in Life Sciences. It’s arguably one of the most prominent recognitions yet for the field ...

AI Summary: Three gene‑therapy researchers received the Breakthrough Prize in recognition of foundational work that enabled the first CRISPR-based sickle cell therapy. The award highlights decades of basic and translational research that turned genome editing from lab curiosity into a tangible clinical remedy, with winners sharing a multimillion‑dollar prize and public acclaim.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #researchfunding #clinicaltrials

5 wks / bbc

6 wks / livescience


Back to Top / Saturday, April 18, 2026, 8:21 pm / permalink 22421 / 9 stories in 6 wks /

Growing liver tissue directly in the body could ease donor organ shortage

medicalxpress - In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary regenerative capacity to repair or compensate for it. Once this "point of no return" has been reached, the only option is an organ tran…

AI Summary: Scientists report a technique to grow liver tissue directly inside the body as a potential solution to donor organ shortages, demonstrating functional hepatic tissue formation in preclinical or early clinical models. The promising results have been followed by an editorial expression of concern over methodology and data, prompting calls for independent validation before wider clinical use.

#healthcare #publichealth #biotech #medicaldevices #researchfunding #clinicaltrials

5 wks / livescience


Back to Top / Saturday, April 18, 2026, 4:23 pm / permalink 22418 / 4 stories in 6 wks /

Eating more fruits and vegetables tied to unexpected lung cancer risk

sciencedaily - A surprising new study suggests that eating a very healthy diet—packed with fruits, vegetables, and whole grains—might be linked to a higher risk of lung cancer in younger non-smokers. Researchers found that patients under 50 diagnosed with lung cancer of…

AI Summary: A new analysis links higher fruit-and-vegetable consumption to an unexpected rise in lung cancer risk among younger non‑smokers, with investigators pointing to pesticide residues on produce as a likely culprit. Researchers urge careful interpretation—don’t ditch your salad—while calling for stricter residue limits, better monitoring, and further study to untangle diet, toxins, and cancer risk.

#publichealth #governmentpolicy #foodsafety #oncology #cancerresearch #researchfunding #nutrition

5 wks / oncodaily

5 wks / newscientist

6 wks / sciencedaily


Back to Top / Saturday, April 18, 2026, 11:22 am / permalink 22406 / 6 stories in 6 wks /

AACR Announces 2026 Distinguished Service Award Recipients

oncodaily - The American Association for Cancer Research (AACR) has announced the recipients of its 2026 Distinguished Service Awards, recognizing individuals whose work has shaped the direction of cancer research, policy, and […]

AI Summary: The American Association for Cancer Research announced its 2026 Distinguished Service Award recipients, honoring leaders for exceptional contributions to cancer research, advocacy, and public engagement. The prizes celebrate scientific leadership across academia, clinical practice, and patient advocacy, reinforcing AACR’s priorities while handing the field a roster of role models to admire—and occasionally envy.


Awards & grants: Distinguished Service, Trailblazers, scholar honors

6 wks / oncodaily

6 wks / oncodaily


Clinical highlights: Trials, company data, and therapeutic developments

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily


On-site coverage: Live updates, press conferences, and recaps

6 wks / oncodaily

6 wks / oncodaily


Other: Attendee reflections and unrelated items

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily


All Other Stories

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily

5 wks / oncodaily



Norway's 'Oslo patient' reaches HIV remission after rare stem cell transplant donated by brother

medicalxpress - A Norwegian man has been effectively cured of HIV after receiving a stem cell transplant from his brother, doctors announced on Monday.

AI Summary: A remarkable clinical case: a patient in Norway known as the "Oslo patient" has entered sustained HIV remission following a rare stem‑cell transplant from a donor with genetic resistance to the virus. The outcome offers cautious optimism for curative strategies, though experts stress this remains an exceptional, high‑risk intervention rather than a broadly applicable cure.

#healthcare #publichealth #biotech #infectiousdisease #researchfunding #clinicaltrials

6 wks / livescience


Back to Top / Saturday, April 18, 2026, 12:23 am / permalink 22368 / 3 stories in 6 wks /

Back to Top


RESEARCHFUNDING Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Digital Health, Weight Loss, Avian Influenza, Price Transparency and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.